SDGR
insider transactionsSchrodinger, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-14.7K
0 buy · 14.7K sell
Net value · 365d
-$190.6K
$0 in · $190.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
13
0 buy · 14.7K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Rachit Jain KEY
EVP & CFO · 10b5-1
$10.8K
844 sh · $12.75
Own -2%
-
Sell·S
CAO · 10b5-1
$7.8K
608 sh · $12.84
Own -2%
-
Sell·S
EVP, CLO & CPO · 10b5-1
$14.1K
1.1K sh · $12.90
Own -2%
-
Sell·S
EVP, CTO & COO, Software · 10b5-1
$15.8K
1.2K sh · $12.90
Own -1%
-
Sell·S
Rachit Jain KEY
EVP & CFO · 10b5-1
$21.0K
1.6K sh · $12.90
Own -3%
-
Sell·S
CAO · 10b5-1
$10.0K
775 sh · $12.85
Own -2%
-
Sell·S
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$17.6K
1.4K sh · $12.90
Own -2%
-
Sell·S
EVP, Chief Scientific Officer… · 10b5-1
$16.7K
1.3K sh · $12.81
Own -2%
-
Grant·A
EVP, CLO & CPO
$0
34.2K sh
Own New
-
Grant·A
EVP, CLO & CPO
$0
13.8K sh
Own +34%
-
Grant·A
EVP, CLO & CPO
$0
17.1K sh
Own +75%
-
Grant·A
EVP, CTO & COO, Software
$0
34.2K sh
Own New
-
Grant·A
EVP, CTO & COO, Software
$0
20.7K sh
Own +30%
-
Grant·A
EVP, CTO & COO, Software
$0
17.1K sh
Own +33%
-
Grant·A
Rachit Jain KEY
EVP & CFO
$0
34.2K sh
Own New
-
Grant·A
Rachit Jain KEY
EVP & CFO
$0
17.1K sh
Own +46%
-
Grant·A
CAO
$0
8.2K sh
Own New
-
Grant·A
CAO
$0
9.6K sh
Own +36%
-
Exercise·M
Director
$0
160.5K sh
Own New
-
Exercise·M
Director
$492.8K
160.5K sh · $3.07
Own +31%
-
Grant·A
EVP, Chief Commercial Officer…
$0
34.2K sh
Own New
-
Grant·A
EVP, Chief Commercial Officer…
$0
17.1K sh
Own +122%
-
Grant·A
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$0
48.5K sh
Own New
-
Sell·S
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$26.5K
2.2K sh · $11.99
Own -3%
-
Grant·A
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$0
27.6K sh
Own +60%
-
Grant·A
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$0
6.1K sh
Own +15%
-
Grant·A
Karen Akinsanya KEY
President, Head of Therapeuti… · 10b5-1
$0
24.2K sh
Own +155%
-
Grant·A
EVP, Chief Scientific Officer…
$0
34.2K sh
Own New
-
Grant·A
EVP, Chief Scientific Officer…
$0
20.7K sh
Own +57%
-
Grant·A
EVP, Chief Scientific Officer…
$0
17.1K sh
Own +88%
-
Sell·S
EVP, CLO & CPO · 10b5-1
$10.7K
776 sh · $13.80
Own -3%
-
Sell·S
EVP, CTO & COO, Software · 10b5-1
$12.7K
925 sh · $13.73
Own -2%
-
Sell·S
CAO · 10b5-1
$10.4K
752 sh · $13.79
Own -3%
-
Sell·S
EVP, Chief Scientific Officer… · 10b5-1
$16.6K
1.2K sh · $13.51
Own -6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Rachit Jain KEY 10b5-1 | Sell S | 844 | $10.8K |
| Mar 6, 2026 | Jenny Herman 10b5-1 | Sell S | 608 | $7.8K |
| Mar 5, 2026 | Yvonne Tran 10b5-1 | Sell S | 1.1K | $14.1K |
| Mar 5, 2026 | Kenneth Patrick Lorton 10b5-1 | Sell S | 1.2K | $15.8K |
| Mar 5, 2026 | Rachit Jain KEY 10b5-1 | Sell S | 1.6K | $21.0K |
| Mar 5, 2026 | Jenny Herman 10b5-1 | Sell S | 775 | $10.0K |
| Mar 5, 2026 | Karen Akinsanya KEY 10b5-1 | Sell S | 1.4K | $17.6K |
| Mar 4, 2026 | Robert Lorne Abel 10b5-1 | Sell S | 1.3K | $16.7K |
| Mar 2, 2026 | Yvonne Tran | Grant A | 34.2K | $0 |
| Mar 2, 2026 | Yvonne Tran | Grant A | 13.8K | $0 |
| Mar 2, 2026 | Yvonne Tran | Grant A | 17.1K | $0 |
| Mar 2, 2026 | Kenneth Patrick Lorton | Grant A | 34.2K | $0 |
| Mar 2, 2026 | Kenneth Patrick Lorton | Grant A | 20.7K | $0 |
| Mar 2, 2026 | Kenneth Patrick Lorton | Grant A | 17.1K | $0 |
| Mar 2, 2026 | Rachit Jain KEY | Grant A | 34.2K | $0 |
| Mar 2, 2026 | Rachit Jain KEY | Grant A | 17.1K | $0 |
| Mar 2, 2026 | Jenny Herman | Grant A | 8.2K | $0 |
| Mar 2, 2026 | Jenny Herman | Grant A | 9.6K | $0 |
| Mar 2, 2026 | Richard Friesner | Exercise M | 160.5K | $0 |
| Mar 2, 2026 | Richard Friesner | Exercise M | 160.5K | $492.8K |
| Mar 2, 2026 | Mannix Vartan Aklian | Grant A | 34.2K | $0 |
| Mar 2, 2026 | Mannix Vartan Aklian | Grant A | 17.1K | $0 |
| Mar 2, 2026 | Karen Akinsanya KEY 10b5-1 | Grant A | 48.5K | $0 |
| Mar 2, 2026 | Karen Akinsanya KEY 10b5-1 | Sell S | 2.2K | $26.5K |
| Mar 2, 2026 | Karen Akinsanya KEY 10b5-1 | Grant A | 27.6K | $0 |
| Mar 2, 2026 | Karen Akinsanya KEY 10b5-1 | Grant A | 6.1K | $0 |
| Mar 2, 2026 | Karen Akinsanya KEY 10b5-1 | Grant A | 24.2K | $0 |
| Mar 2, 2026 | Robert Lorne Abel | Grant A | 34.2K | $0 |
| Mar 2, 2026 | Robert Lorne Abel | Grant A | 20.7K | $0 |
| Mar 2, 2026 | Robert Lorne Abel | Grant A | 17.1K | $0 |
| Feb 10, 2026 | Yvonne Tran 10b5-1 | Sell S | 776 | $10.7K |
| Feb 10, 2026 | Kenneth Patrick Lorton 10b5-1 | Sell S | 925 | $12.7K |
| Feb 10, 2026 | Jenny Herman 10b5-1 | Sell S | 752 | $10.4K |
| Feb 9, 2026 | Robert Lorne Abel 10b5-1 | Sell S | 1.2K | $16.6K |
About SDGR insider trading
This page tracks insider transactions for Schrodinger, Inc. (SDGR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.